AKEBIA THERAPEUTICS INC (AKBA)

US00972D1054 - Common Stock

1.24  -0.02 (-1.59%)

After market: 1.26 +0.02 (+1.61%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
194.62M292.50M211.70M294.60M335.00M
Cost Of Goods
39.74M22.50M103.10M132.20M112.50M
Gross Profit
154.88M270.00M108.50M162.40M222.50M
Operating Expenses
199.35M304.70M358.10M405.30M508.80M
Research and Development
63.08M130.00M147.90M218.50M323.00M
Selling, General, and Administrative Expenses
100.23M138.60M174.10M154.10M149.50M
Operating Income
-44.48M-34.70M-249.50M-242.80M-286.30M
Interest Income/Expense
-6.03M-15.70M-19.90M-8.90M800.00K
Other Income/Expense
887.00K3.10M2.40M1.90M-800.00K
Non Recurring Items
-2.31M-47.00M-15.00M-135.00MN/A
Income Before Taxes
-51.92M-94.20M-282.00M-384.80M-286.30M
Income Tax
N/A0.000.000.00-6.60M
Net Income
-51.92M-94.20M-282.00M-384.80M-279.70M
EBITDA
-6.85M2.99M-211.53M-209.20M-247.65M
 
Per Share Data
EPS Diluted Total Ops
-0.28-0.52-1.70-2.78-2.36
Non GAAP EPS
-0.28-0.44-1.70-1.93-2.36
 
Statistics
Gross Profit Margin
79.58%92.31%51.25%55.13%66.42%
Profit Margin
-26.68%-32.21%-133.21%-130.62%-83.49%
Operating Profit Margin
-22.85%-11.86%-117.86%-82.42%-85.46%

All data in USD

Charts